Page last updated: 2024-12-05

trifenmorph

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trifenmorph, also known as tridemorph, is a fungicide used to control powdery mildew in various crops. It is synthesized through a series of reactions involving chlorination, alkylation, and condensation. Trifenmorph inhibits the biosynthesis of ergosterol, a crucial component of fungal cell membranes, leading to disruption of cell growth and development. It exhibits both preventive and curative action against powdery mildew. Due to its effectiveness and relatively low toxicity to mammals, trifenmorph is widely used in agriculture. However, concerns regarding its potential environmental impact and the emergence of resistant fungal strains have led to ongoing research on its mode of action, alternative fungicides, and sustainable practices.'

trifenmorph: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14993
CHEMBL ID2086832
CHEBI ID82264
SCHEMBL ID435727
MeSH IDM0042375

Synonyms (36)

Synonym
unii-h1il51k9cw
h1il51k9cw ,
trifenmorph [iso:bsi]
caswell no. 898a
wl 8008
einecs 215-812-2
triphenmorphe
ai3-51843
morpholine, n-trityl-
n-tritylmorpholine
frescon
n-(triphenyl-methyl)morpholine
epa pesticide chemical code 498300
morpholine, 4-(triphenylmethyl)-
morpholine, 4-trityl-
trifenmorph
4-tritylmorpholine
hsdb 1785
shell wl 8008
brn 1223254
4-(triphenylmethyl)morpholine
NCGC00160549-01
AKOS003382578
C19144
1420-06-0
chebi:82264 ,
CHEMBL2086832
trifenmorph [hsdb]
trifenmorph [mart.]
trifenmorph [mi]
trifenmorph [iso]
SCHEMBL435727
n-(triphenylmethyl)morpholine
DTXSID6042492
4-tritylmorpholine #
Q27155848

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" This order was the same in oligocalcic water with Echinogammarus berilloni; with Gammarus pulex, CuCl2 was more toxic than Triphenmorph."( [Comparative study of the toxicity of metal chlorides and a synthetic organic molluscacide, N-tritylmorpholine, in 2 fresh-water amphipods, Gammarus pulex and Echinogammarus berilloni].
Debord, J; Penicaut, B; Vincent, M, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
morpholinesAny compound containing morpholine as part of its structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID684467Inhibition of apolipoprotein E production in human CCF-STTG1 cells at 10 uM after 24 hrs by ELISA relative to vehicle-treated control2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Design, synthesis and identification of a new class of triarylmethyl amine compounds as inhibitors of apolipoprotein E production.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (85.71)18.7374
1990's1 (7.14)18.2507
2000's0 (0.00)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.52 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.12 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]